You have 9 free searches left this month | for more free features.

Canton (2)

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations (1)

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation (1)

Recruiting (2)

phase 2 (1)

phase 3 (1)

Taiho Oncology, Inc. (2)

tas6417 (2)

drug (2)

Industry (2)

Interventional (2)

tas6417

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jul 25, 2023

Recruiting

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Jul 21, 2023